Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT05044884 Completed - COPD Clinical Trials

Effects of Otago Exercise Program vs Circuit Training on Balance in Chronic Obstructive Pulmonary Disease Patients

COPD
Start date: September 10, 2021
Phase: N/A
Study type: Interventional

The study is designed to compare circuit training and otago exercise program for improvement of balance in COPD patients. Although both techniques are effective for balance training but Otago exercise program is home-based exercise program, which, if proven effective, will help the COPD patients to do work up at home, thereby reducing cost of hospital visits and improving balance ability and thus the quality of life more effectively.

NCT ID: NCT05035875 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluation of Diaphragm in Chronic Obstructive Pulmonary Disease Patients by Ultrasound in Relation to Severity

Start date: December 14, 2019
Phase:
Study type: Observational

The study of the diaphragm is an important point in the assessment of COPD patients. Ultrasonographic evaluation of the diaphragm is considered a simple, non-invasive, available bedside technique. Ultrasonography can be used for evaluation of the site, structure, and motion of the diaphragm, assessment of excursion, and thickness. The aim of the study is ultrasonographic assessment of the diaphragm in COPD patients and its relation to disease severity

NCT ID: NCT05029557 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

The Effect of Education Based on the Chronic Care Model in COPD Patients

Start date: December 27, 2021
Phase: N/A
Study type: Interventional

Individuals who have COPD need a nursing service, which provides qualified and effective professional care, self-care, and supportive care to perform their daily life activities, and improve their quality of life. It is predicted that the Chronic Care-Based Training Program to be implemented and the follow-ups can increase the level of self-efficacy and satisfaction, and raise awareness on the management of the disease in patients. The purpose of the study was to evaluate the effects of the Chronic Care Model based education and telephone follow-up given to patients with COPD on self-efficacy and patient-reported outcomes. Also, the Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease-mCOPD-PRO scale, which will be used in the study, will be adapted into Turkish language and culture, and will be used in the study after its validity and reliability are examined.

NCT ID: NCT04999930 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Tiotropium Respimat Administration With and Without Aerochamber Disease (COPD)

Start date: January 10, 2020
Phase: N/A
Study type: Interventional

COPD patient on Tiotropium Respimart divided into two group, Group A given aerochamber and Group B without aerochamber enroll in the study for total 18 week .

NCT ID: NCT04990180 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Pulmonary Rehabilitation Shared Decision Making Intervention

PReSent
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

The PReSent study seeks to clarify the need, develop and test the feasibility and acceptability of a shared decision making intervention to support patients with Chronic Obstructive Pulmonary Disease make decisions about Pulmonary Rehabilitation. The study is split into two parts; (1) an observational study of healthcare professionals implicit attitudes, and (2) a feasibility and acceptability study assessing the value of the newly developed shared decision making intervention including a patient decision aid and decision coaching.

NCT ID: NCT04988282 Completed - Covid19 Clinical Trials

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

STERCOV-ILD
Start date: May 24, 2021
Phase: Phase 4
Study type: Interventional

Aim: To investigate the efficacy of systemic corticosteroids in treatment for Post-COVID-19 Interstitial Lung Disease. Method: Method: In this multi-centre, prospective, randomised controlled open label clinical trial, patients are divided into two arms: standard treatment arm and standard plus systemic corticosteroid arm. After twelve weeks; clinical, functional, and radiological improvement will being assessed as primary outcomes.

NCT ID: NCT04987606 Completed - COVID-19 Pneumonia Clinical Trials

Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions

POSTCODE
Start date: July 1, 2021
Phase:
Study type: Observational

This study aims to understand why some people who have had COVID-19 develop scarring of the lungs and why some people recover more quickly than others.

NCT ID: NCT04982809 Completed - Clinical trials for Interstitial Lung Disease

Cost-effectiveness Analysis of Three Corticosteroids in ILDs

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This was a 3 months prospective, open label, and parallel study to test the efficacy of 3 different corticosteroids in the management of interstitial lung diseases. Followed by a pharmacoeconomic analysis to find which regimen (betamethasone, dexamethasone or prednisolone) is the most cost-effective.

NCT ID: NCT04978883 Completed - Sjogren's Syndrome Clinical Trials

Interstitial Lung Diseases in Primary Sjogren's Syndrome

Start date: January 1, 2016
Phase:
Study type: Observational

Patients with pSS seen in the Division of Rheumatology, the second affiliated hospital of Zhejiang University, School of Medicine (SAHZU) during January 2016 to July 2018, were retrospectively reviewed. Characteristics were analyzed.

NCT ID: NCT04953611 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Quantitative Study on HRCT Phenotype of COPD

Start date: July 1, 2013
Phase:
Study type: Observational

To explore the HRCT phenotype of the combined COPD assessment staging system